Procter & Gamble Company (PG) Financials

Key financial figures for Procter & Gamble Company (Q1 2027).

P&G Q1 FY2027 net sales rose 4% to $23.3B with organic sales +4% and core EPS $2.00 (+1%); FY2027 all-in sales guidance raised to +2% to +4% for the Thorne acquisition while organic and EPS growth ranges were maintained. Net sales were $23,276M, up 4% from $22,386M a year ago; organic sales also grew 4%, driven by a 2% volume increase and a 1% favorable mix, with pricing a minor positive. Diluted EPS was $1.97, up 1% from $1.95; core EPS was $2.00, up 1% from $1.99. Currency-neutral core EPS was unchanged at $1.99. Every segment grew organically: Beauty +5%, Grooming +5%, Health Care +3%, Fabric & Home Care +5%, Baby, Feminine & Family Care +3%. Health Care organic volume fell 3% and was offset by pricing and mix. On the outlook: FY2027: all-in sales growth raised to +2% to +4% (was +1% to +3%) to reflect the Thorne acquisition as of October 1, 2026; organic sales growth maintained at +1% to +3% (including a 30 to 50 bps headwind from discontinuations); diluted EPS growth maintained at +1% to +5% off $6.62; core EPS growth maintained at in-line to +3% off $6.89 ($6.89 to $7.11, $7.00 midpoint). Cost headwind now estimated at $0.79 per share, an eleven percent drag on core EPS growth (previously $0.56, eight percent): about $1.4B after tax from commodities, energy and transportation (was about $1.0B), $300M from higher net interest expense (was $150M), $150M from lower non-operating income and $50M from foreign exchange. Core tax rate 20% to 21% (was about 20%). Free cash flow productivity 85% to 90% maintained; over $10B of dividends and about $5B of buybacks. Figures are for Q1 FY2027, as Procter & Gamble Company reported them.

Revenue

$23.3B

Net Income

$4.7B

EPS

$2.00

Total Assets

$133.1B

Operating Cash Flow

$5.8B

Full income statement, balance sheet and cash flow for Procter & Gamble Company on SentiSense, with up to forty quarters and twenty fiscal years of history.